Dear Reader,
MARK DOWN THIS DATE: JUNE 13!
That's when this new "cancer-killing gel" will shake the markets.
Why am I telling you all of this now??
So you can get in on the ground floor of the small firm that invented it while shares are still trading for around $10.
Because there's no telling how big this move could be.
Wall Street analysts see this firm reaching as high as $40 a share.
And to be honest, I think that's underselling it.
Here's why...
This isn't just any FDA approval.
This new miracle makes surgery OBSOLETE!
In clinical trials, this new miracle therapy had a mind-blowing 79.6% complete response rate after three months with no signs of cancer.
And at 12 months, 82.3% of patients were still cancer-free
So this isn't just about removing the cancer, it's about making sure it's gone for good.
With NO cutting and NO scary surgeries!
Now this firm is sitting on a market of 80,000 patients a year in the U.S., worth over $5 billion!
OR 10 TIMES its current market cap.
So don't get left behind, because the big money is already moving on this one.
Get in on the ground floor now.
To your success,
Brian Hicks
Founder and President, Angel Investment Research
P.S. Imagine a gel delivered directly to the tumor in a quick office visit, instead of repeated, painful surgeries. Get in before FDA approval on June 13.
Tidak ada komentar:
Posting Komentar